Celgene Corp (CELG)

CELG (NASDAQ:Drugs) EQUITY
$108.79
pos +0.00
+0.00%
Today's Range: 107.50 - 110.13 | CELG Avg Daily Volume: 4,563,400
Last Update: 08/26/16 - 4:00 PM EDT
Volume: 0
YTD Performance: -9.16%
Open: $0.00
Previous Close: $107.91
52 Week Range: $93.05 - $128.39
Oustanding Shares: 775,114,702
Market Cap: 83,642,627,493
6-Month Chart
TheStreet Ratings Grade for CELG
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 14 14 13 13
Moderate Buy 0 0 1 1
Hold 3 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.35 1.35 1.41 1.41
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 45.34
Price Earnings Comparisons:
CELG Sector Avg. S&P 500
45.34 52.40 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
2.85% -8.76% 54.14%
GROWTH 12 Mo 3 Yr CAGR
Revenue 20.70 0.70 0.19
Net Income -19.90 0.10 0.03
EPS -18.80 0.20 0.06
Earnings for CELG:
EBITDA 2.96B
Revenue 9.26B
Average Earnings Estimates
Qtr (09/16) Qtr (12/16) FY (12/16) FY (12/17)
Average Estimate $1.31 $1.37 $5.10 $6.36
Number of Analysts 4 4 4 4
High Estimate $1.33 $1.39 $5.17 $6.50
Low Estimate $1.29 $1.33 $5.05 $6.21
Prior Year $1.12 $1.00 $4.08 $5.10
Growth Rate (Year over Year) 16.74% 36.50% 25.06% 24.60%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
By

Doug Kass

 | Aug 24, 2016 | 2:53 PM EDT
The U.S. dollar is stronger. The price of crude oil fell by $1.33 to $46.77. Gold slipped by $17 to $1,329 and appears likely to threaten support at $1,300 to $1,310. Agricultural commodities. wheat -2, corn -1.5, soybean -9, oats flat. Lumber -7 on weak housing data. Bonds are down small. The 10- and 30-year note and bond yields are unchanged. So was the 2s/10s spread (80 basis points). Municipals and junk flat lined, as did Blackstone/GSO Strategic Credit Fund (BGB) and closed-end muni bond funds. Banks remain the world's fair.: Brokerages are holding in well. Same goes for insurance, but my long Hartford Financial Services Group (HIG) is a laggard. Biotech down by about 2%. Allergan (AGN) and Celgene (CELG) are leaders to the downside, with speculative biotech taken to the woodshed, too. Profit-taking continues in retail. Autos are mixed. Energy stocks nonplussed by oil's descent, thus far. Old tech is mixed, but IBM (IBM) is a downside feature. Media is down small. Ag equipment is weaker (I dissed CAT this morning, added to my short) Staples are lower on a stronger currency. In individual stocks, my longs Radian Group (RDN) and DuPont (DD) are doing God's work! Oaktree Capital Group (OAK) is trading better, but it is an odd stock and it's mostly difficult to understand its daily moves. (T)FANG all lower, but not materially. Here are some valuable contributions on our site today: Jim "El Capitan" Cramer on oil and the little guy.  Tim "Not Judy or Phil" Collins sees Babe Ruth -- i.e., Facebook (FB) -- striking out.  Skip Raschke on frowning (and shorting). Rev Shark is waiting for Godot.  Roger Arnold on a rate rise by the Fed (Fischer-style). 
By

Bret Jensen

 | Aug 22, 2016 | 10:31 AM EDT
Las Vegas Sands (LVS) continues to show strength after Bank of America/Merrill Lynch put out an optimistic note this morning about Macau gambling. Energy is weak in early trading. Oil has drifted back down to around $47 a barrel following its recent roughly 20% rally.
By

James Passeri

 | Aug 18, 2016 | 11:55 AM EDT

RBC Capital analysts say splitting the company into two distinct businesses would free 'trapped value' on drug treatments.

By

Bret Jensen

 | Aug 11, 2016 | 12:00 PM EDT
These are the biggest errors that I've made over the years.
By

Bret Jensen

 | Aug 4, 2016 | 12:04 PM EDT
These sectors offer value as the S&P 500 trades at 19x earnings.
By

Jim Cramer

 | Aug 3, 2016 | 3:38 PM EDT
With enough of earnings season now under our belt, we check out the promising themes and the sectors to avoid.
By

Bret Jensen

 | Aug 2, 2016 | 11:00 AM EDT
The sector seems to be rebounding after tumbling by more than 40%.
By

Doug Kass

 | Aug 1, 2016 | 2:23 PM EDT
Biotech is dancing off of the stock screen, especially the more speculative merchandise. In large cap bio, Celgene (CELG) remains an upside standout. I don't have a dog in the hunt. Apple (AAPL) is still recovering from the earnings report date last week. I will give the stock some leeway before adding to my short. Walmart (WMT) is the world's fair. Amazon's (AMZN) streak is intact, as is Alphabet's (GOOGL) . This is contributing to continued strength of QQQs over SSSs. Twitter (TWTR) -- arguably the world's most hated stock these days -- continues to climb, albeit slowly. I have recently added post-earnings. My favorite large-cap, DuPont (DD) , holds up well and seems to have a mission to reach $70. I will have an update in the next few days. The Bad Bonds are the day's lows. I continue to see a generational bottom in yields, as noted a few weeks ago when the 10-year U.S. note yield breached 1.35%. Energy stocks are finally catching up to the drop in crude oil prices. I don't find en
By

Bret Jensen

 | Aug 1, 2016 | 1:00 PM EDT
The bifurcation can be seen just by looking at Apple's recent results.
By

Jim Cramer

 | Aug 1, 2016 | 12:07 PM EDT
That may be the best way to get through the notorious month of August.

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.